Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN343185 - Provider product page

- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN343185, RRID:AB_11208900
- Product name
- anti-Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL) antibody
- Antibody type
- Polyclonal
- Antigen
- KLH-conjugated peptide derived from the sequence of human glycogen debranching enzyme P35573
- Description
- serum
- Reactivity
- Human, Mouse, Rat, Rabbit
- Host
- Rabbit
- Vial size
- 200 μg
- Storage
- -20°C
- Handling
- Please, remember to spin tubes briefly prior to opening them to avoid any losses that might occur from lyophilized material adhering to the cap or sides of the tubes. Once reconstituted make aliquots to avoid repreated freeze-thaw cycles.
Submitted references Commentary on: "Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study." Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, Heidenreich A, Iversen P, Braeckman J, Heracek J, Baskin-Bey E, Ouatas T, Perabo F, Phung D, Hirmand M, Smith MR. Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: bertrand.tombal@uclouvain.be. Aarhus University Hospital, Aarhus, Denmark. Herlev Hospital, Herlev, Denmark. AZ Groeninge Kortrijk, Kortrijk, Belgium. UZ Leuven, Leuven, Belgium. Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. UZ Brussel, Brussels, Belgium. Univerzita Karlova v Praze, Prague, Czech Republic. Astellas Pharma Global Development, Leiden, Netherlands. Astellas Pharma Global Development, Northbrook, IL, USA. Medivation Inc, San Francisco, CA, USA. Massachusetts General Hospital Cancer Center, Boston, MA, USA: Lancet Oncol. 2014 May;15(6):592-600; doi: 10.1016/S1470-2045(14)70129-9. [Epub 2014 Apr 14].
Glycogen storage disease type III: A novel Agl knockout mouse model.
AMP-activated protein kinase does not associate with glycogen alpha-particles from rat liver.
Trump D
Urologic oncology 2015 Apr 30;
Urologic oncology 2015 Apr 30;
Glycogen storage disease type III: A novel Agl knockout mouse model.
Pagliarani S, Lucchiari S, Ulzi G, Violano R, Ripolone M, Bordoni A, Nizzardo M, Gatti S, Corti S, Moggio M, Bresolin N, Comi GP
Biochimica et biophysica acta 2014 Nov;1842(11):2318-28
Biochimica et biophysica acta 2014 Nov;1842(11):2318-28
AMP-activated protein kinase does not associate with glycogen alpha-particles from rat liver.
Parker GJ, Koay A, Gilbert-Wilson R, Waddington LJ, Stapleton D
Biochemical and biophysical research communications 2007 Nov 3;362(4):811-5
Biochemical and biophysical research communications 2007 Nov 3;362(4):811-5
No comments: Submit comment
No validations: Submit validation data